Pemetrexed Baxter Euroopan unioni - italia - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - agenti antineoplastici - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

DEXMEDETOMIDINA BAXTER Italia - italia - AIFA (Agenzia Italiana del Farmaco)

dexmedetomidina baxter

baxter holding bv - dexmedetomidina - dexmedetomidina

Inpremzia Euroopan unioni - italia - EMA (European Medicines Agency)

inpremzia

baxter holding b.v. - insulin human (rdna) - diabete mellito - farmaci usati nel diabete - inpremzia is indicated for the treatment of diabetes mellitus.